jon_doe50

Xeris Biopharma would turn Cashflow positive EOY 2022 according to RBC (profitable != cashflow positive). $XERS currently burns ~$25M per quarter and has ~$135M as of 3/31/2021. Assuming a constant...
Current 2025E from RBC is $257M. Source: https://twitter.com/Corona_N_Lyme/status/1397182354599419911 If the current $350M market grows by 20% CAGR until then Xeris market share would be ~30%.